BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35484365)

  • 1. Trends in Use of High-Cost Antihyperglycemic Drugs Among US Adults with Type 2 Diabetes.
    Le P; Bui TC; Abramowitz J; Herman WH; Misra-Hebert AD; Rothberg MB
    J Gen Intern Med; 2023 Jan; 38(1):49-56. PubMed ID: 35484365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey.
    Le P; Chaitoff A; Misra-Hebert AD; Ye W; Herman WH; Rothberg MB
    Diabetes Care; 2020 Jun; 43(6):1227-1233. PubMed ID: 32234720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
    Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-series analysis of recent antihyperglycemic medication prescribing trends for a diverse sample of Medicare enrollees with type 2 diabetes mellitus in an integrated health system.
    Miller MJ; DiNucci AJ; Jalalzai R; Rabinovich N; Roblin DW
    Am J Health Syst Pharm; 2022 Jun; 79(12):950-959. PubMed ID: 35176753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Demographic Factors Associated With Diabetic Retinopathy Among Young Patients With Diabetes.
    Ferm ML; DeSalvo DJ; Prichett LM; Sickler JK; Wolf RM; Channa R
    JAMA Netw Open; 2021 Sep; 4(9):e2126126. PubMed ID: 34570208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Medicaid Reimbursements for Insulin From 1991 Through 2014.
    Luo J; Avorn J; Kesselheim AS
    JAMA Intern Med; 2015 Oct; 175(10):1681-6. PubMed ID: 26301721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Insulin Types and Devices Used by Adults With Type 2 Diabetes in the United States, 2016 to 2020.
    Sarkar S; Heyward J; Alexander GC; Kalyani RR
    JAMA Netw Open; 2021 Oct; 4(10):e2128782. PubMed ID: 34636912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Diabetic Prescription Drug Utilization and Costs Among Patients With Diabetes Enrolled in Colorado Marketplace and Medicaid Plans, 2014-2015.
    Khorrami P; Sinha MS; Bhanja A; Allen HL; Kesselheim AS; Sommers BD
    JAMA Netw Open; 2022 Jan; 5(1):e2140371. PubMed ID: 35029667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of comorbid conditions and race/ethnicity on glycemic control among the US population with type 2 diabetes, 1988-1994 to 1999-2004.
    Suh DC; Choi IS; Plauschinat C; Kwon J; Baron M
    J Diabetes Complications; 2010; 24(6):382-91. PubMed ID: 19716320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018.
    He J; Zhu Z; Bundy JD; Dorans KS; Chen J; Hamm LL
    JAMA; 2021 Oct; 326(13):1286-1298. PubMed ID: 34609450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and Disparities in Glycemic Control and Severe Hyperglycemia Among US Adults With Diabetes Using Insulin, 1988-2020.
    Venkatraman S; Echouffo-Tcheugui JB; Selvin E; Fang M
    JAMA Netw Open; 2022 Dec; 5(12):e2247656. PubMed ID: 36538330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Antiobesity Treatment and Weight-Inducing Antihyperglycemic Agents Among Patients With Type 2 Diabetes in the United States.
    Levin A; Kaur N; Mainoo NK; Perez A
    Clin Ther; 2022 Mar; 44(3):e35-e44. PubMed ID: 35105470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System.
    Lamprea-Montealegre JA; Madden E; Tummalapalli SL; Peralta C; Neilands TB; Garcia PK; Muiru A; Karliner L; Shlipak MG; Estrella MM
    JAMA; 2022 Sep; 328(9):861-871. PubMed ID: 36066519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018.
    McAdam-Marx C; Ruiz-Negron N; Sullivan JM; Tucker JM
    J Manag Care Spec Pharm; 2022 May; 28(5):494-506. PubMed ID: 35392659
    [No Abstract]   [Full Text] [Related]  

  • 16. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.
    Afkarian M; Zelnick LR; Hall YN; Heagerty PJ; Tuttle K; Weiss NS; de Boer IH
    JAMA; 2016 Aug; 316(6):602-10. PubMed ID: 27532915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.
    Gross JL; Kramer CK; Leitão CB; Hawkins N; Viana LV; Schaan BD; Pinto LC; Rodrigues TC; Azevedo MJ;
    Ann Intern Med; 2011 May; 154(10):672-9. PubMed ID: 21576535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial ethnic differences in type 2 diabetes treatment patterns and glycaemic control in the Boston Area Community Health Survey.
    Goonesekera SD; Yang MH; Hall SA; Fang SC; Piccolo RS; McKinlay JB
    BMJ Open; 2015 May; 5(5):e007375. PubMed ID: 25967997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.